Cargando…
Anti-tumor effects of brucine immuno-nanoparticles on hepatocellular carcinoma
BACKGROUND: Hepatocellular carcinoma is difficult to diagnose early, and most patients are already in the late stages of the disease when they are admitted to hospital. The total 5-year survival rate is less than 5%. Recent studies have showed that brucine has a good anti-tumor effect, but high toxi...
Autores principales: | Qin, Jian-Min, Yin, Pei-Hao, Li, Qi, Sa, Zhong-Qiu, Sheng, Xia, Yang, Lin, Huang, Tao, Zhang, Min, Gao, Ke-Pan, Chen, Qing-Hua, Ma, Jing-Wei, Shen, He-Bai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273973/ https://www.ncbi.nlm.nih.gov/pubmed/22334771 http://dx.doi.org/10.2147/IJN.S27226 |
Ejemplares similares
-
Antitumor effects of brucine immuno-nanoparticles on hepatocellular carcinoma in vivo
por: Qin, Jianmin, et al.
Publicado: (2018) -
Pharmacological investigation of brucine anti-ulcer potential
por: Noman, Muhammad, et al.
Publicado: (2022) -
Stoichiometric and Nonstoichiometric Hydrates of Brucine
por: Braun, Doris E., et al.
Publicado: (2016) -
Development, optimization, and evaluation of PEGylated brucine-loaded PLGA
nanoparticles
por: Elsewedy, Heba S., et al.
Publicado: (2020) -
Study of pharmacokinetics and tissue distribution of liposomal brucine for dermal administration
por: Yang, Bai-Can, et al.
Publicado: (2011)